M MENVEO Trademark

Trademark Overview


On Wednesday, November 12, 2008, a trademark application was filed for M MENVEO with the United States Patent and Trademark Office. The USPTO has given the M MENVEO trademark a serial number of 77612913. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 22, 2016. This trademark is owned by Novartis AG. The M MENVEO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
m menveo

General Information


Serial Number77612913
Word MarkM MENVEO
Filing DateWednesday, November 12, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 22, 2016
Registration Number3638831
Registration DateTuesday, June 16, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements


Indication of Colors claimedThe color(s) purple, light brown, beige and pink is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a stylized letter "M" followed by the word "MENVEO". The word "MENVEO" appears in pink. The vertical bars of the stylized "M" appear in purple. The left side of the top of the stylized "M" appears in light brown and the right side of the top of the stylized "M" appears in beige.
Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGLAXOSMITHKLINE BIOLOGICALS S.A.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRIXENSART B-1330
BE

Party NameGLAXOSMITHKLINE BIOLOGICALS S.A.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address1330 RIXENSART
BE

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Friday, January 22, 2016CANCELLED SEC. 8 (6-YR)
Wednesday, August 26, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 22, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 8, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 2, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 2, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 16, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Tuesday, February 24, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 23, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 16, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 16, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 14, 2009TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 15, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 15, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 15, 2009ASSIGNED TO LIE
Friday, January 9, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 15, 2008NON-FINAL ACTION MAILED
Sunday, December 14, 2008NON-FINAL ACTION WRITTEN
Wednesday, December 3, 2008ASSIGNED TO EXAMINER
Tuesday, November 18, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Monday, November 17, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords


menveo human vaccines